Donepezil and Memantine in Moderate to Severe Alzheimer’s Disease
Condition(s):Moderate to Severe Alzheimer’s DiseaseLast Updated:March 20, 2009Unknown status
Hide Studies Not Open or Pending
Condition(s):Moderate to Severe Alzheimer’s DiseaseLast Updated:March 20, 2009Unknown status
Condition(s):Epileptic Encephalopathy, Childhood-OnsetLast Updated:March 11, 2022Completed
Condition(s):EpilepsyLast Updated:July 11, 2017Completed
Condition(s):Autism Spectrum DisorderLast Updated:March 20, 2017Completed
Condition(s):Parkinson’s Disease; Cognitive Impairment; DementiaLast Updated:September 12, 2017Completed
Condition(s):Chronic SchizophreniaLast Updated:June 27, 2019Terminated
Condition(s):Lupus Erythematosus, SystemicLast Updated:May 22, 2023Recruiting
Condition(s):Bipolar II DisorderLast Updated:March 9, 2021Unknown status
Condition(s):Ischemic Stroke; Excitotoxicity; MemantineLast Updated:October 6, 2020Completed
Condition(s):Obsessive-Compulsive DisorderLast Updated:August 20, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.